D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 40 Citations 10,013 83 World Ranking 16999 National Ranking 478

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Genetics

Molecular biology, Progenitor cell, Cellular differentiation, Cell culture and Immunology are his primary areas of study. The various areas that he examines in his Molecular biology study include After treatment, Gene rearrangement, Chromosomal translocation and Carcinogen. The study incorporates disciplines such as Haematopoiesis and Growth factor in addition to Progenitor cell.

His Haematopoiesis study incorporates themes from Myeloid and Bone marrow. His Cellular differentiation research is multidisciplinary, incorporating elements of Stem cell factor and Cell biology. His work deals with themes such as microRNA and Cell growth, which intersect with Stem cell factor.

His most cited work include:

  • MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation (705 citations)
  • MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation (705 citations)
  • KDR Receptor: A Key Marker Defining Hematopoietic Stem Cells (470 citations)

What are the main themes of his work throughout his whole career to date?

Mauro Valtieri focuses on Haematopoiesis, Molecular biology, Cell biology, Progenitor cell and Immunology. The concepts of his Haematopoiesis study are interwoven with issues in CD34, Growth factor, Cellular differentiation and Bone marrow. His study in Molecular biology is interdisciplinary in nature, drawing from both Interleukin 3, Endocrinology, Gene expression, Internal medicine and microRNA.

His biological study spans a wide range of topics, including Proto-Oncogene Proteins c-myb, Cell culture and Erythropoietin receptor. His work in the fields of Cell culture, such as Transfection, overlaps with other areas such as Expression vector. His Immunology research includes themes of Interleukin 12, Cancer research and Tumor suppressor gene.

He most often published in these fields:

  • Haematopoiesis (61.54%)
  • Molecular biology (55.77%)
  • Cell biology (41.35%)

What were the highlights of his more recent work (between 2004-2018)?

  • Cell biology (41.35%)
  • Mesenchymal stem cell (11.54%)
  • Bone marrow (21.15%)

In recent papers he was focusing on the following fields of study:

His main research concerns Cell biology, Mesenchymal stem cell, Bone marrow, Molecular biology and microRNA. His research integrates issues of Phenotype, Cell, Genetics and In vitro growth in his study of Cell biology. His research investigates the link between Bone marrow and topics such as Stromal cell that cross with problems in Regenerative medicine.

Mauro Valtieri interconnects mir-223, Cell culture and Chromosomal translocation in the investigation of issues within Molecular biology. The Cell culture study combines topics in areas such as Stem cell factor, In vitro, Cell growth and Cellular differentiation. His work is dedicated to discovering how Transfection, Progenitor cell are connected with Haematopoiesis and other disciplines.

Between 2004 and 2018, his most popular works were:

  • MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation (705 citations)
  • MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation (705 citations)
  • The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein (403 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Genetics

His primary scientific interests are in microRNA, Bone marrow, Cell growth, Cellular differentiation and Immunology. Much of his study explores microRNA relationship to Cancer research. His Bone marrow research incorporates elements of Stromal cell, Regenerative medicine and Cell biology.

His Cell growth research integrates issues from Cell culture, Transfection, Progenitor cell, Stem cell factor and Molecular biology. As part of his studies on Cellular differentiation, Mauro Valtieri frequently links adjacent subjects like Chondrogenesis. Mauro Valtieri focuses mostly in the field of Immunology, narrowing it down to topics relating to Mesenchymal stem cell and, in certain cases, Exosome, Paracrine signalling, Molecular medicine and Microvesicles.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation

Nadia Felli;Laura Fontana;Elvira Pelosi;Rosanna Botta.
Proceedings of the National Academy of Sciences of the United States of America (2005)

994 Citations

KDR Receptor: A Key Marker Defining Hematopoietic Stem Cells

B. L. Ziegler;M. Valtieri;M. Valtieri;G. Almeida Porada;R. De Maria;R. De Maria.
Science (1999)

655 Citations

The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein

Paolo Neviani;Ramasamy Santhanam;Rossana Trotta;Mario Notari.
Cancer Cell (2005)

550 Citations

High-Efficiency Gene Transfer and Selection of Human Hematopoietic Progenitor Cells with a Hybrid EBV/Retroviral Vector Expressing the Green Fluorescence Protein

Francesco Grignani;Todd Kinsella;Amedea Mencarelli;Mauro Valtieri.
Cancer Research (1998)

443 Citations

Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line.

M. Valtieri;D. J. Tweardy;D. Caracciolo;Keith R Johnson.
Journal of Immunology (1987)

407 Citations

Identification of the hemangioblast in postnatal life.

Elvira Pelosi;Mauro Valtieri;Simona Coppola;Rosanna Botta.
Blood (2002)

351 Citations

Multi-Level Effects of flt3 Ligand on Human Hematopoiesis: Expansion of Putative Stem Cells and Proliferation of Granulomonocytic Progenitors/Monocytic Precursors

M. Gabbianelli;E. Pelosi;E. Montesoro;M. Valtieri.
Blood (1995)

320 Citations

Isolation and characterization of CD146+ multipotent mesenchymal stromal cells.

Antonio Sorrentino;Manuela Ferracin;Germana Castelli;Mauro Biffoni.
Experimental Hematology (2008)

314 Citations

Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines

B Lange;M Valtieri;D Santoli;D Caracciolo.
Blood (1987)

308 Citations

Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging.

Bruno Calabretta;Robert B. Sims;Mauro Valtieri;Daniele Caracciolo.
Proceedings of the National Academy of Sciences of the United States of America (1991)

304 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mauro Valtieri

Ugo Testa

Ugo Testa

Istituto Superiore di Sanità

Publications: 88

Carlo M. Croce

Carlo M. Croce

The Ohio State University

Publications: 78

Cesare Peschle

Cesare Peschle

Istituto Superiore di Sanità

Publications: 66

Bruno Calabretta

Bruno Calabretta

Thomas Jefferson University

Publications: 58

Kay Huebner

Kay Huebner

The Ohio State University

Publications: 43

Pier Giuseppe Pelicci

Pier Giuseppe Pelicci

European Institute of Oncology

Publications: 39

Cesare Peschle

Cesare Peschle

Istituto Superiore di Sanità

Publications: 38

George A. Calin

George A. Calin

The University of Texas MD Anderson Cancer Center

Publications: 36

Anna Rita Migliaccio

Anna Rita Migliaccio

University of Bologna

Publications: 33

Alan M. Gewirtz

Alan M. Gewirtz

University of Pennsylvania

Publications: 31

Michael A. Caligiuri

Michael A. Caligiuri

City Of Hope National Medical Center

Publications: 27

Renato Baserga

Renato Baserga

Thomas Jefferson University

Publications: 21

Saverio Minucci

Saverio Minucci

European Institute of Oncology

Publications: 20

Alan D. Friedman

Alan D. Friedman

Johns Hopkins University

Publications: 20

Clara Nervi

Clara Nervi

Sapienza University of Rome

Publications: 19

Bruno Péault

Bruno Péault

University of Edinburgh

Publications: 19

Trending Scientists

Sanjay Chawla

Sanjay Chawla

Qatar Computing Research Institute

P. G. L. Leach

P. G. L. Leach

University of KwaZulu-Natal

Yuan Gao

Yuan Gao

Agency for Science, Technology and Research

Erik Fridell

Erik Fridell

Chalmers University of Technology

Mihai Peterca

Mihai Peterca

University of Pennsylvania

Tsutomu Minegishi

Tsutomu Minegishi

University of Tokyo

James Camakaris

James Camakaris

University of Melbourne

Daniel F. Cutler

Daniel F. Cutler

University College London

Martin Morgan

Martin Morgan

Roswell Park Cancer Institute

Christoph E. Schreiner

Christoph E. Schreiner

University of California, San Francisco

Antonia F. de C. Hamilton

Antonia F. de C. Hamilton

University College London

Afaf Girgis

Afaf Girgis

University of New South Wales

Carl R. Rogers

Carl R. Rogers

Henry Ford Health System

Gregory M. Brown

Gregory M. Brown

Centre for Addiction and Mental Health

Susan L. Mitchell

Susan L. Mitchell

Harvard University

Henian Chen

Henian Chen

University of South Florida

Something went wrong. Please try again later.